PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

OrbiMed

NeRRe Therapeutics Raises £23 million in an oversubscribed Series B financing round.

Israeli cancer detection company Nucleix raises $3 million from Aurum Ventures, Orbimed etc.

Israeli investment firm Orbimed closes medical fund at $307M

ObsEva, Swiss biopharma company, nets $60M Series B from HBM Healthcare Investments, NEA, OrbiMed, Rock Springs Capital and Sofinnova Partners

SmartZyme closes funding round of $4M led by Orbimed

Therachon, achondroplasia therapy developer, raises $35M in Series A round, led by OrbiMed

TytoCare, a consumer-focused telehealth company, closes a $11M Series B round led by Cambia Health Solutions

Echosens, a specialist in non-invasive diagnostic products, raises capital from Cathay Capital Private Equity and Orbimed

Nabriva Therapeutics, a biotechnology company, completes a $120M Series B financing